Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials-Reference-Cited by-同舟云学术

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

Published:2019-10 Issue:10 Volume:7 Page:776-785
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Kristensen Søren L,Rørth Rasmus,Jhund Pardeep S,Docherty Kieran F,Sattar Naveed,Preiss David,Køber Lars,Petrie Mark C,McMurray John J V

Funder

University of Oxford BHF Centre of Research Excellence Senior Transition Fellowship

BHF Centre of Research Excellence award

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference29 articles.

1. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Davies;Diabetes Care,2018

2. 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease

3. Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus;Zelniker;Circulation,2019

4. Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD-1 SU);Marre;Diabet Med,2009

5. Biology of incretins: GLP-1 and GIP;Baggio;Gastroenterology,2007

Cited by 1092 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in molecular recognition and ultrasensitive detection of growth-promoting drug residues in meat and meat products;Trends in Food Science & Technology;2024-11

2. Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction;Heart Failure Reviews;2024-09-13

3. INCIDÊNCIA DE PANCREATITE AGUDA DEVIDO AO USO DE AGONISTAS DO RECEPTOR DE GLP-1;RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218;2024-09-13

4. Slowing the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes Using Four Pillars of Therapy: The Time to Act is Now;Drugs;2024-09-11

5. Comparison of glucagon-like peptide-1 receptor agonists vs. placebo on any cardiovascular events in overweight or obese non-diabetic patients: a systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2024-09-11